Dark

TBPH
Theravance Biopharma, Inc.
stock NASDAQ

At Close

Jul 17, 2026 3:59:50 PM EDT

16.94USD-0.177%(-0.03)449,526

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-16.97)0

After-hours

Jul 17, 2026 4:04:30 PM EDT

16.96USD+0.118%(+0.02)117,324

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

877.45M

CEO

Rick Winningham

Headquarters

George Town, Grand Cayman, Cayman Islands

Industry

Biotechnology

Next Earnings

Aug 11, 2026 (24d)

CORT CPIX COLL XLV

TBPH Stats

Avg. Vol. 10 Day

603,053

Avg. Vol. 30 Day

747,355

Employees

340

Market Cap

877,452,340

Shares Out.

51,828,254

On/Off Exchange

66%/34%

6 Month Beta

0.66

1 Year Beta

0.67

2 Year Beta

0.55

3 Year Beta

0.55

52 Week Low

10.82

52 Week High

21.03

SMA50

16.64

SMA200

16.93

1 Month

+2.11%

3 Month

-1.74%

6 Month

-17.09%

1 Year

+50.49%

2 Year

+74.90%

5 Year

+26.63%

Profile

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

TBPH Stock Summary

Theravance Biopharma, Inc. (NASDAQ:TBPH) stock price today is $16.94, and today's volume is 449,526. TBPH is down -0.177% today. The 30 day average volume is 747,355. TBPH market cap is 877.45M with 51,828,254 shares outstanding.